Back to Research Hub
Processa Pharmaceuticals, Inc.
PCSA
$2.54+0.30 (+13.39%)
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States.
StreetsValue research for Processa Pharmaceuticals, Inc. (PCSA)
Members get the full report for Processa Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.